Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 October 2018 Photo Anja Aucamp
Itumeleng Tsatsi - Using Occupational Therapy to tackle mental health
“Every opportunity you get is a chance that leads you to your goals, making the best of it; a journey of a thousand steps begins with just one.” - Itumeleng Tsatsi

Polokwane-born Itumeleng Tsatsi, junior lecturer in Occupational Therapy at the University of the Free State (UFS), pledged to improve the quality of life of South African citizens through her study and practice of Occupational Therapy.

Itumeleng Tsatsi was named in the Mail and Guardian Top 200 list of South Africans under the age of 35 who have done exceptional work in their fields, aiming to uplift their society.

Tsatsi explained that working as a clinician at the Thabamoopo Psychiatric Hospital in Lebowakgomo, Limpopo, lit a fire in her that was charged at dissociating and destigmatising the views that people associate with the term ‘mental health’.  Her focus as an occupational therapist zooms mostly into tackling mental-health issues and the injustices faced by people, making use of the services offered in the system.

World Mental Health Day is observed on 10 October every year, with the overall objective of raising awareness of mental-health issues around the world, and mobilising efforts in support of mental health. Tsatsi elaborated that one of the many challenges she faced in clinical practice, was the constructed theories of mental health that were too westernised and did not meet the needs of South African populations, particularly in the rural areas. Her aim is to create a niche area in academia and train occupational therapists to care for their citizens on a practical basis and not only through textbook guidelines that aren’t entirely applicable to the South African context.

With October being Mental Health Awareness Month, Tsatsi further highlighted that she wants to optimise the training of Occupational Therapy students at the UFS by ensuring that their attitude towards mental health as a specialisation in their field is a positive one, due to the growing number of South Africans subjected to mental-health issues today. 

Furthermore, her study aims to empower mental-healthcare users to speak up about their experiences in mental-health institutions, to aid their reintegration into communities and create supportive environments where they can equally contribute to society. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept